| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |